IL10 and idiopathic pulmonary fibrosis: Among these, the group treated with MSCs alone showed the highest stimulatory effect on IL-10 expression, indicating that MSCs may be more potent in upregulating anti-inflammatory pathways in the lung tissues affected by IPF.